BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3488191)

  • 1. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
    Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
    Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media.
    Marchant CD; Shurin PA; Johnson CE; Murdell-Panek D; Feinstein JC; Fulton D; Flexon P; Carlin SA; Van Hare GF
    J Pediatr; 1986 Nov; 109(5):891-6. PubMed ID: 3534203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
    Marchant CD; Carlin SA; Johnson CE; Shurin PA
    J Pediatr; 1992 Jan; 120(1):72-7. PubMed ID: 1731027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent and penicillin V-resistant otitis media. A treatment study with amoxycillin/clavulanate and cefaclor.
    Jacobsson S; Rignér P; von Sydow C; Bondesson G
    Acta Otolaryngol; 1988; 106(3-4):171-7. PubMed ID: 3140574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentin (amoxycillin-clavulanic acid) compared with co-trimoxazole in urinary tract infections.
    Fancourt GJ; Matts SG; Mitchell CJ
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):82-3. PubMed ID: 6428687
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of Branhamella catarrhalis to oral antibiotics.
    Kallings I
    Drugs; 1986; 31 Suppl 3():17-22. PubMed ID: 3488193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae.
    Schwartz RH; Rodriguez WJ; Khan WN; Mann R; Barsanti RG; Ross S
    Rev Infect Dis; 1982; 4(2):514-6. PubMed ID: 6981169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy.
    Lundgren K; Ingvarsson L
    Drugs; 1986; 31 Suppl 3():125-31. PubMed ID: 3488192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
    Easton J; Noble S; Perry CM
    Drugs; 2003; 63(3):311-40. PubMed ID: 12534334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Otitis media and sinusitis in children. Role of Branhamella catarrhalis.
    Bluestone CD
    Drugs; 1986; 31 Suppl 3():132-41. PubMed ID: 3732081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections.
    Bailey RR; Bishop V; Peddie B; Chambers PF; Davies PR; Crofts HG
    N Z Med J; 1983 Nov; 96(744):970-2. PubMed ID: 6605501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media.
    Marchant CD; Shurin PA; Turcyzk VA; Feinstein JC; Johnson CE; Wasikowski DE; Knapp LJ; Tutihasi MA
    J Pediatr; 1984 Oct; 105(4):633-8. PubMed ID: 6384453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.
    Wallace RJ; Steele LC; Brooks DL; Luman JI; Wilson RW; McLarty JW
    Antimicrob Agents Chemother; 1985 Jun; 27(6):912-5. PubMed ID: 3875310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.